Keywords

• Clevidipine 99%
• pharmaceutical
• Clevidipine

Quick Details

• ProName: High quality Clevidipine
• CasNo: 167221-71-8
• Molecular Formula: C21H23Cl2NO6
• Appearance: off-white to pale yellow crystalline p...
• Application: for the reduction of blood pressure wh...
• DeliveryTime: 3days
• PackAge: 10g/pack,100g/pack,1kg/pack
• Port: shanghai port
• ProductionCapacity: 10000 Kilogram/Year
• Purity: 99%min
• Storage: dry and cool place
• Transportation: by EMS,FEDEX
• LimitNum: 1 Kilogram

Superiority

1.In No Less five years exporting experience.

2.Lower Price with higher quality

3,Free sample

4,We are sincerely responsible for the "product quality" and "After Service"

Onchem (China) Co.,Ltd  is Specialized in APIs, chemical intermediates, herbal extract and pharmaceutical raw materials.

Details

(1) Company Introduction:

    Onchem (China) Co.,Ltd  is a comprehensive manufacturer and an international distribution of chemicals throughout the 

world. Specialized in APIs, chemical intermediates, herbal extract and pharmaceutical raw materials. our products sell

well in Europe, U.S.A., Japan and Korea, Southeast Asia, Taiwan and other country.

(2) Product Detail 

English name:Clevidipine

Specification: 99%

CAS NO.:167221-71-8

Appearance: off-white to pale yellow crystalline powder

Molecular weight:456.32

Molecular formula:C₂₁H₂₃Cl₂NO₆

Packaging & Delivery:

Payment terms:

1:Sample order: we advise that you can use west-union

2: if big order: we accept T/T100% .

3:Delievry:after reived your full payment, we will send the product within 3-5days.

MOQ: Sample MOQ: Min 1kg-25kg available. Throght by EMS/DHL/TNT/UPS etc.

After we send the product, we will send the track number to you with E-mail, and also we will track this order until you can received successfully.

 Welcome to Onchem (China) Co.,Ltd, and welcome to inquiry me about all our products, we will provice the 

(3) Application

    Clevidipine is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral

therapy is not feasible or not desirable.

(4)  Factory Picture: